HEPATITIS C ANTIVIRALS

The present invention relates to deoxyribozymes targeting and cleaving HCV RNA. More particularly, the present invention relates to deoxyribozymes and composition used for the inhibition of HCV replication and HCV-related diseases. L'invention concerne des deoxyribozymes permettant de cibler et...

Full description

Saved in:
Bibliographic Details
Main Authors MOMPARLER, RICHARD, TANNER, JEROME, E, ALFIERI, CAROLINA, TREPANIER, JANIE
Format Patent
LanguageEnglish
French
Published 31.05.2007
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
DERIVATIVES THEREOF
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
NUCLEIC ACIDS
NUCLEOSIDES
NUCLEOTIDES
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
SPIRITS
SUGARS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to deoxyribozymes targeting and cleaving HCV RNA. More particularly, the present invention relates to deoxyribozymes and composition used for the inhibition of HCV replication and HCV-related diseases. L'invention concerne des deoxyribozymes permettant de cibler et de cliver l'ARN-VHC. L'invention concerne plus particulièrement des deoxyribozymes et des composition utilisée pour inhiber la réplication de VHC et les maladies associées à VHC.
Bibliography:Application Number: WO2006CA01282